Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

AbbVie and Janssen announce failure of cancer drug Imbruvica in Phase 3 trial

July 12, 2018 Research and Development AbbVie, Cancer, FDA, Janssen, approval

AbbVie and Janssen have announced that Imbruvica (ibrutinib) failed to achieve the primary endpoint in a late-stage study assessing its …
News
celgene_building

Celgene and Acceleron’s blood disorder drug smashes endpoints at Phase 3

July 11, 2018 Research and Development Acceleron, Celgene, beta-thalassemia, luspatercept, pharma

Celgene and Acceleron have lifted the curtain on new Phase 3 data for their erythroid maturation agent (EMA) luspatercept, confirming …
News
westminster-parliament-resized

UK Government announces £10m antimicrobial resistance research competition

July 11, 2018 Research and Development 10 million, antimicrobial, competition, government, resistance

The UK Government’s Department of Health and Social Care has announced the launch of a £10 million research competition aimed …
News
28246711066_52e38bc591_z

EMA survey identifies gaps in pharma industry’s preparedness for Brexit

July 11, 2018 Research and Development CAPS, EEA, EMA, brexit, preparedness

An EMA survey has identified gaps in the pharmaceutical industry’s preparedness for Brexit, finding that only 58% of market authorisation …
News

Wellcome Trust announces £250m fund for high risk ideas

July 11, 2018 Research and Development 250 million, Wellcome, britain, leap fund, pharma

The London-based biomedical research charity the Wellcome Trust, Britain’s wealthiest foundation, has announced the launch of a new £250 million …
News
shutterstock_254160583

Trump forces Pfizer to back down and delay price hikes until 2019

July 11, 2018 Research and Development, Sales and Marketing Alex Azar, Donald Trump, Ian Read, Pfizer, President trump, Trump, druig pricing, pharma

Trump bared his teeth, and it paid off. Following his call-out of Pfizer after the US pharma giant ignored the …
News
mario_saltarelli_cropped

Syntimmune appoints Pfizer, AbbVie veteran as new CMO

July 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, John Hopkins University, Pfizer, Syntimmune

The Boston-based clinical biotechnology company Syntimmune has appointed Dr Mario Saltarelli as its Chief Medical Officer. Dr Saltarelli will take …
Appointment

NICE calls to limit antibiotic use in COPD over antimicrobial resistance fears

July 10, 2018 Manufacturing and Production, Medical Communications, Research and Development COPD, NICE, antimicrobial resistance, chronic obstructive pulmonary disease, pharma

NICE have published a draft antimicrobial prescribing guide recommending that healthcare professionals should consider the risk of antimicrobial resistance when …
News

Eisai and Biogen’s Alzheimer’s drug slows progression in Phase 2 trials

July 9, 2018 Research and Development, Sales and Marketing

The Japan-based Eisai and Massachusetts-based Biogen have announced that experimental drug BAN2401 has demonstrated efficacy in slowing the progression of …
News
shutterstock_212035546

Extended use of breast cancer drug tamoxifen linked to increased endometrial cancer risk

July 9, 2018 Research and Development, Sales and Marketing Cancer, breast cancer, endometrial cancer, pharma, tamoxifen

New evidence published in the British Journal of Surgery has indicated a troubling link between long-term use of the breast …
News

Insider Interview: Biosimilars to balance the books

July 9, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, bisoimilars, multiple sclerosis

Jean-Yves Brault, Country Manager at Mylan UK, discusses how biosimilars are going to play an important role in driving down …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week

July 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Astrazenaca, Donald Trump, Pfizer, pharma, top ten

As the first week of July comes to an end we take a look over the most popular stories of …
News
michel_porro-getty_images

Zynerba’s cannabis-based transdermal patch fails at Phase 1, shares slide 21%

July 6, 2018 Medical Communications, Research and Development GW Pharma, Zynerba, cannabidinol, cannabinol, cannabis, pharma, trial failure

As public focus on the issue of medicinal cannabis continues to grow, Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol …
News
shutterstock_gonnorrhea

Ipsen reveals positive Phase 3 data of Cabometyx in liver cancer

July 5, 2018 Research and Development Cabometyx, Cancer, ipsen, liver cancer, pharma

French pharmaceutical company Ipsen has announced that The New England Journal of Medicine has published the results of a Phase …
News
640px-hiv-budding-color

Abivax drug lowers HIV DNA in blood and tissue, but has the opposite effect for some

July 4, 2018 Research and Development Abivax, HIV, pharma

Biotechnology firm Abivax has lifted the curtain on new Phase 2a data for its HIV therapy ABX464, showing that the …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026